Hinterland Metals Inc. builds a network of clinics, retreats, and research sites to serve the regulated psychedelics industry in the United States. It operates in two segments, Cedar Psychiatry and Cedar Research. The company offers outpatient mental health services; and manages and hosts third party clinical trials and participates in institutional review board studies. It also provides ketamine-assisted psychotherapy and other therapies; retreat network services; and clinical research for psychedelic medicines. The company is headquartered in Toronto, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.31    OTCQB
As of 01/24/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Index country:  Canada
Country of incorporation:  
IPO date:  06/17/2021
Outstanding shares:  42,835,901
Average volume:  16,178
Market cap:   $13,394,786
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   -1.25
PB ratio:   1.37
PS ratio:   1.99
Return on equity:   -109.50%
Net income %:   -159.07%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy